Cargando…
Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer
A good prognosis can be expected for most, but not all, cases of thyroid papillary cancer. Numerous molecular studies have demonstrated beneficial treatment and prognostic factors in various molecular markers. Whereas most previous reports have focused on genomics and proteomics, few have focused on...
Autores principales: | Ishikawa, Seiji, Tateya, Ichiro, Hayasaka, Takahiro, Masaki, Noritaka, Takizawa, Yoshinori, Ohno, Satoshi, Kojima, Tsuyoshi, Kitani, Yoshiharu, Kitamura, Morimasa, Hirano, Shigeru, Setou, Mitsutoshi, Ito, Juichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490946/ https://www.ncbi.nlm.nih.gov/pubmed/23139822 http://dx.doi.org/10.1371/journal.pone.0048873 |
Ejemplares similares
-
Increased phosphatidylcholine (16:0/16:0) in the folliculus lymphaticus of Warthin tumor
por: He, Qian, et al.
Publicado: (2014) -
Erratum to: Increased phosphatidylcholine (16:0/16:0) in the folliculus lymphaticus of Warthin tumor
por: He, Qian, et al.
Publicado: (2014) -
The Distribution of Phosphatidylcholine Species in Superficial-Type Pharyngeal Carcinoma
por: Ishikawa, Seiji, et al.
Publicado: (2017) -
Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion
por: Yamazaki, Kaori, et al.
Publicado: (2015) -
Stimulated Bronchial Epithelial Cells Release Bioactive Lysophosphatidylcholine 16:0, 18:0, and 18:1
por: Zhuge, Yan, et al.
Publicado: (2014)